Global Radioligand Therapies Market to Expand at a 12.7% CAGR Through 2035
Market Overview According to MarketGenics, the global Radioligand Therapies (RLT) Market is experiencing significant growth, driven by advancements in targeted cancer treatments and precision oncology. Radioligand therapies combine radioactive isotopes with targeting molecules that identify specific cancer cells, delivering radiation directly to tumors while limiting exposure to surrounding...
0 Commenti 0 condivisioni 52 Views